/

Other

/

Paratek Pharmaceuticals

Paratek Pharmaceuticals

Paratek Pharmaceuticals

Verified Nov 2026

Other

·

United States flag

Boston, Massachusetts

·

Since 1996

Paratek Pharmaceuticals is a Boston-based biopharmaceutical company founded in 1996 with 200–500 employees and revenue in the $100–250M band. It develops small-molecule therapies focused on infectious diseases and antimicrobial resistance, serving civilian, government, and military sectors. The company markets NUZYRA® for bacterial pneumonia and skin infections, and SEYSARA® for acne, and completed a combination with Radius Health in March 2026.

Paratek Pharmaceuticals

Verified Nov 2026

AT A GLANCE

Founded

1996

Headquarters

United States flag

Boston, Massachusetts

Employees

200-500

Ownership

Paratek Pharmaceuticals at a glance

Revenue

$100-250M

Est. band

Employees

200-500

Founded

1996

Headquarters

Boston, Massachusetts

Industries

Automotive

Electric Vehicles

Medical

Military & Defense

Overview

Paratek Pharmaceuticals is a Boston-based biopharmaceutical company founded in 1996 with 200–500 employees and revenue in the $100–250M band. It develops small-molecule therapies focused on infectious diseases and antimicrobial resistance, serving civilian, government, and military sectors. The company markets NUZYRA® for bacterial pneumonia and skin infections, and SEYSARA® for acne, and completed a combination with Radius Health in March 2026.

At a glance

Attribute

Detail

Founded

1996

Headquarters

Boston, Massachusetts

Employees

200-500

Revenue

$100-250M (estimated)

What Paratek Pharmaceuticals makes

Paratek specializes in tetracycline chemistry to create antimicrobial therapies targeting resistant pathogens and addressing public health threats.

Latest developments

Company details

The company maintains offices in Boston, Massachusetts and King of Prussia, Pennsylvania, and is recognized as one of independent antibiotics companies globally. Paratek Pharmaceuticals was founded in 1996, has an estimated 200-500 employees, and is headquartered in Boston, Massachusetts.

Frequently asked questions

What does Paratek Pharmaceuticals do?

Paratek Pharmaceuticals is a Boston-based biopharmaceutical company founded in 1996 with 200–500 employees and revenue in the $100–250M band. It develops small-molecule therapies focused on infectious diseases and antimicrobial resistance, serving civilian, government, and military sectors. The company markets NUZYRA® for bacterial pneumonia and skin infections, and SEYSARA® for acne, and completed a combination with Radius Health in March 2026.

Where is Paratek Pharmaceuticals headquartered?

Paratek Pharmaceuticals is headquartered in Boston, Massachusetts (75 Park Plaza, Boston, Massachusetts, 02116).

When was Paratek Pharmaceuticals founded?

Paratek Pharmaceuticals was founded in 1996.

How big is Paratek Pharmaceuticals?

Paratek Pharmaceuticals has an estimated 200-500 employees, with revenue in the $100-250M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Boston, Massachusetts (HQ)Headquarters · United States
Boston, Massachusetts (HQ)75 Park Plaza, Boston, Massachusetts, 02116, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.